PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Current smokers with early rheumatoid arthritis less responsive to TNF inhibitors, methotrexate

Past smoking history does not affect RA patients' response to treatments

2011-01-06
(Press-News.org) Patients with early rheumatoid arthritis (RA) who are current smokers were less likely to achieve good response to methotrexate (MTX) and tumor necrosis factor (TNF) inhibitors than those who never smoked. The study by researchers from Sweden also found that RA patients who smoked in the past did not experience a lower response to these therapies. Results of the 10-year study appear in the January 2011 issue of Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR).

According to the World Health Organization (WHO), approximately 0.8% of adults (age 15 and older) worldwide have RA—a chronic autoimmune disease characterized by inflammation, pain, and swelling in the joints. Current medical evidence points to smoking as a known risk factor for RA development and globally, WHO estimates there are more than one billion smokers. However limited data are available on the impact of cigarette smoking and response to pharmacological therapy in early RA.

In the current study, Saedis Saevarsdottir, MD, PhD and colleagues from Karolinska University Hospital and Karolinska Institute in Stockholm investigated the influence cigarette smoking has on response to MTX and TNF inhibitor treatment in early RA. The team used clinical data for 1430 patients entering the epidemiological investigation of rheumatoid arthritis (EIRA) between 1996 and 2006. EIRA is a population-based case-control study in Sweden comprising RA patients between the ages of 18 and 70, who were enrolled on average 10 months from symptom onset. Of the participants, 873 started MTX monotherapy upon entering EIRA, and 535 started TNF inhibitor therapy, on average 3 years after the diagnosis.

Results indicated that at three months following the start of MTX current smokers were less likely to achieve a EULAR "good response"1 compared to those who never smoked (27% vs. 36%); (29% vs. 43%) following the start of TNF inhibitors. Researchers evaluated the entire cohort for all treatments used and found current smoking was associated with less chance of a good response (odds ratio for 3 months = 0.61, 6 months = 0.65, 1 year = 0.78, 2 years = 0.66, 5 years = 0.61). Past smoking history did not affect the patients' response to MTX or TNF inhibitors.

"We also found that only 14% of current smokers who did not start any disease modifying treatment at baseline reached the good response category after 3 months, compared to 34% of RA patients who never smoked," confirmed Dr. Saevarsdottir. The authors recommend further studies to determine if discontinuation of smoking prior to initiating treatment would be beneficial. Dr. Saevarsdottir concluded, "Our findings provide strong evidence that clinicians should include smoking cessation programs as part of their standard therapeutic arsenal in caring for patients with RA."

1 In accordance with recent guidelines from the European League against Rheumatism (EULAR) and the ACR, the study team used the EULAR response criteria, based on the 28-joint disease activity score (DAS28), to define response to treatment with "good response" considered a DAS28 less than 3.2 at the follow-up visit and greater than 1.2 units decrease compared to the baseline DAS28.

INFORMATION:

Article: "Patients with Early Rheumatoid Arthritis Who Smoke are Less Likely to Respond to Treatment with Methotrexate and TNF Inhibitors. Observations from the EIRA Cohort and the Swedish Rheumatology Register." Saedis Saevarsdottir, Sara Wedrén, Maria Seddighzadeh,Camilla Bengtsson, Annmarie Wesley, Staffan Lindblad, Johan Askling, Lars Alfredsson and Lars Klareskog. Arthritis & Rheumatism; Published Online: December 28, 2010 (DOI: 10.1002/art.27758); Print Issue Date: January 2011. http://onlinelibrary.wiley.com/doi/10.1002/art.27758/abstract

This study is published in Arthritis & Rheumatism. Media wishing to receive a PDF of the article may contact healthnews@wiley.com.

About the Journal

Arthritis & Rheumatism is an official journal of the American College of Rheumatology (ACR) and the Association of Rheumatology Health Professionals (ARHP), a division of the College, and covers all aspects of inflammatory disease. The American College of Rheumatology (www.rheumatology.org) is the professional organization who share a dedication to healing, preventing disability, and curing the more than 100 types of arthritis and related disabling and sometimes fatal disorders of the joints, muscles, and bones. Members include practicing physicians, research scientists, nurses, physical and occupational therapists, psychologists, and social workers. For details, please visit http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1529-0131.

About Wiley-Blackwell

Wiley-Blackwell is the international scientific, technical, medical, and scholarly publishing business of John Wiley & Sons, with strengths in every major academic and professional field and partnerships with many of the world's leading societies. Wiley-Blackwell publishes nearly 1,500 peer-reviewed journals and 1,500+ new books annually in print and online, as well as databases, major reference works and laboratory protocols. For more information, please visit www.wileyblackwell.com or our new online platform, Wiley Online Library (wileyonlinelibrary.com), one of the world's most extensive multidisciplinary collections of online resources, covering life, health, social and physical sciences, and humanities.

END



ELSE PRESS RELEASES FROM THIS DATE:

Accurate interpretation of antinuclear antibodies test key to confirming autoimmune disease

2011-01-06
The presence of antinuclear antibodies (ANA) indicates the possibility of autoimmunity and the indirect immunofluorescence (IIF) assay on HEp-2 cells is the standard blood test (ANA-HEp-2) used to detect ANA. However, studies have shown that a "false-positive" ANA test occurs in up to 13% of healthy individuals. In such cases the test detects the presence of autoantibodies that apparently are not associated with autoimmunity. Researchers from Brazil have now uncovered distinguishing characteristics of the ANA test in healthy individuals and patients with autoimmune disease, ...

Smithsonian instrument 'fills the gap,' views sun's innermost corona

Smithsonian instrument fills the gap, views suns innermost corona
2011-01-06
During a total eclipse of the Sun, skywatchers are awed by the shimmering corona -- a faint glow that surrounds the Sun like gossamer flower petals. This outer layer of the Sun's atmosphere is, paradoxically, hotter than the Sun's surface, but so tenuous that its light is overwhelmed by the much brighter solar disk. The corona becomes visible only when the Sun is blocked, which happens for just a few minutes during an eclipse. Now, an instrument on board NASA's Solar Dynamics Observatory (SDO), developed by Smithsonian scientists, is giving unprecedented views of the ...

Clinical practitioners not adhering to evidence-based guidelines for osteoarthritis

2011-01-06
New research found clinicians who care for patients with osteoarthritis (OA) are likely not following standard care guidelines that are based on current medical evidence. Researchers noted physicians were prescribing medications for pain and inflammation, or opting for surgical interventions rather than recommending weight loss plans or exercise programs to OA patients. Details of the this study are available in the January 2011 issue of Arthritis Care & Research, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology. A 2002 report ...

New solar cell self-repairs like natural plant systems

New solar cell self-repairs like natural plant systems
2011-01-06
WEST LAFAYETTE, Ind. - Researchers are creating a new type of solar cell designed to self-repair like natural photosynthetic systems in plants by using carbon nanotubes and DNA, an approach aimed at increasing service life and reducing cost. "We've created artificial photosystems using optical nanomaterials to harvest solar energy that is converted to electrical power," said Jong Hyun Choi, an assistant professor of mechanical engineering at Purdue University. The design exploits the unusual electrical properties of structures called single-wall carbon nanotubes, using ...

Wake up and smell the willow

2011-01-06
More plant matter could be burned in coal-fired power stations if this 'green' fuel was delivered pre-roasted like coffee beans, according to researchers from the University of Leeds, UK. Many UK power stations are now burning plant matter, or biomass, as well as coal in a bid to cut their carbon footprint. Unlike fossil fuels, plants like willow, Miscanthus and poplar are a virtually carbon-neutral source of energy: the carbon dioxide emitted when they burn is absorbed during photosynthesis by the next batch of 'energy crops' planted in their place. But the environmental ...

US does not have infrastructure to consume more ethanol

US does not have infrastructure to consume more ethanol
2011-01-06
WEST LAFAYETTE, Ind. - The United States doesn't have the infrastructure to meet the federal mandate for renewable fuel use with ethanol but could meet the standard with significant increases in cellulosic and next-generation biofuels, according to a Purdue University study. Wally Tyner, the James and Lois Ackerman Professor of Agricultural Economics, and co-authors Frank Dooley, a Purdue professor of agricultural economics, and Daniela Viteri, a former Purdue graduate student, used U.S. Department of Energy and Environmental Protection Agency data to determine that the ...

Environmental Science & Technology special issue on environmental policy now online

2011-01-06
WASHINGTON, Jan. 4, 2011 — A special edition of the American Chemical Society journal, Environmental Science & Technology (ES&T), one of the world's premier environmental journals, is available now for a limited time online without charge. The special edition will be accessible free during 2011, when the world celebrates the International Year of Chemistry. Entitled "Environmental Policy: Past, Present, and Future," the special issue of ES&T recognizes closure of a "green" decade in which people became more aware of environmental issues, and society marked the 40th anniversaries ...

Vaccine blocks cocaine high in mice

2011-01-06
NEW YORK (Jan. 4, 2011) — Researchers have produced a lasting anti-cocaine immunity in mice by giving them a safe vaccine that combines bits of the common cold virus with a particle that mimics cocaine. In their study, published Jan. 4 in the online edition of Molecular Therapy and funded by the National Institute on Drug Abuse, the researchers say this novel strategy might be the first to offer cocaine addicts a fairly simple way to break and reverse their habit, and it might also be useful in treating other addictions, such as to nicotine, heroin and other opiates. ...

VCU findings may help explain some major clinical symptoms of preeclampsia

2011-01-06
RICHMOND, Va. (Jan. 4, 2011) – Virginia Commonwealth University School of Medicine researchers have found that a significant increase of an enzyme in the blood vessels of pregnant women with preeclampsia may explain some of the symptoms associated with the condition, including hypertension, swelling and protein in the urine. The findings could lead to a treatment for pregnant women with preeclampsia, which is one of the most significant health problems in pregnancy and a leading cause worldwide of both premature delivery and of sickness and death of the mother and baby. Preeclampsia, ...

Scientists discover that a specific enzyme inhibitor may help control lung inflammation

2011-01-06
All of us may be able to breathe a little easier now that scientists from Pennsylvania have found a new therapeutic target for controlling dangerous inflammation in the lungs. A new research report in the January 2011 issue of the Journal of Leukocyte Biology (http://www.jleukbio.org) suggests that blocking the activation of an enzyme called delta-protein kinase C (delta-PKC) could protect the lungs from neutrophil-mediated damage, which can result in out of control inflammation. In an animal model of acute respiratory distress syndrome (ARDS), inhibiting delta-PKC in ...

LAST 30 PRESS RELEASES:

Underserved youth less likely to visit emergency department for concussion in Ontario, study finds

‘Molecular shield’ placed in the nose may soon treat common hay fever trigger

Beetles under climate stress lay larger male eggs: Wolbachia infection drives adaptive reproduction strategy in response to rising temperature and CO₂

Groundbreaking quantum study puts wave-particle duality to work

Weekly injection could be life changing for Parkinson’s patients

Toxic metals linked to impaired growth in infants in Guatemala

Being consistently physically active in adulthood linked to 30–40% lower risk of death

Nerve pain drug gabapentin linked to increased dementia, cognitive impairment risks

Children’s social care involvement common to nearly third of UK mums who died during perinatal period

‘Support, not judgement’: Study explores links between children’s social care involvement and maternal deaths

Ethnic minority and poorer children more likely to die in intensive care

Major progress in fertility preservation after treatment for cancer of the lymphatic system

Fewer complications after additional ultrasound in pregnant women who feel less fetal movement

Environmental impact of common pesticides seriously underestimated

The Milky Way could be teeming with more satellite galaxies than previously thought

New study reveals surprising reproductive secrets of a cricket-hunting parasitoid fly

Media Tip Sheet: Symposia at ESA2025

NSF CAREER Award will power UVA engineer’s research to improve drug purification

Tiny parasitoid flies show how early-life competition shapes adult success

New coating for glass promises energy-saving windows

Green spaces boost children’s cognitive skills and strengthen family well-being

Ancient trees dying faster than expected in Eastern Oregon

Study findings help hone precision of proven CVD risk tool

Most patients with advanced melanoma who received pre-surgical immunotherapy remain alive and disease free four years later

Introducing BioEmu: A generative AI Model that enables high-speed and accurate prediction of protein structural ensembles

Replacing mutated microglia with healthy microglia halts progression of genetic neurological disease in mice and humans

New research shows how tropical plants manage rival insect tenants by giving them separate ‘flats’

Condo-style living helps keep the peace inside these ant plants

Climate change action could dramatically limit rising UK heatwave deaths

Annual heat-related deaths projected to increase significantly due to climate and population change

[Press-News.org] Current smokers with early rheumatoid arthritis less responsive to TNF inhibitors, methotrexate
Past smoking history does not affect RA patients' response to treatments